Matchpoint Therapeutics
- Website
- matchpointtx.com
- Total Funding
- $100.0M
- Last Round
- $70.0M Series AOct 2022
- Rounds
- 2
About
Precision covalent medicines for immune diseases
Summary
It has raised $100.0M in total across 2 rounds, most recently a $70.0M Series A round in Oct 2022. Investors include Atlas Venture, Sanofi Ventures and Access Biotechnology.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.